Home » Topics » Regulatory » Patents

Patents
RSS

IURTC presents anti-HBV agents

Nov. 2, 2016

Bayer Pharma describes HSKM-B inhibitors

Nov. 2, 2016

AbbVie discloses TNF-alpha modulators

Nov. 2, 2016

Celgene Quanticel Research patents brodomain inhibitors

Nov. 2, 2016

Bristol-Myers Squibb presents novel indoleamine 2,3-dioxygenase inhibitors

Oct. 31, 2016

Bayer Pharma identifies new N-lysine methyltransferase SMYD2 inhibitors

Oct. 31, 2016

Hawaii Biotech describes new Botulinum neurotoxin type A light chain inhibitors

Oct. 31, 2016

AbbVie discloses novel TNF-alpha modulators

Oct. 31, 2016

Plexxikon divulges FLT3 mutant inhibitors for leukemia

Oct. 28, 2016

Dana-Farber Cancer Institute patent describes CDK inhibitors

Oct. 28, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...